EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
16.870 |
Evidence |
O
|
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
16.870 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
16.670 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
16.670 |
Evidence |
O
|
EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
SKIV2L |
SKIV2L, XXbac-BCX116I9.5-001, XXbac-BPG116M5.1-001: Superkiller viralicidic acti |
16.570 |
Evidence |
O
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
PCAF |
PCAF: Histone acetyltransferase PCAF |
16.570 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
16.570 |
Evidence |
|
RELA |
RELA, NFKB3: Transcription factor p65 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
16.570 |
Evidence |
|
TCF8 |
ZEB1, AREB6, TCF8: Zinc finger E-box-binding homeobox 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
16.570 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
16.570 |
Evidence |
O
|
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
16.570 |
Evidence |
|
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
WDR77 |
WDR77, HKMT1069, hCG_39991: Androgen receptor cofactor p44 |
16.420 |
Evidence |
|
HCK |
IPI00029769 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
16.420 |
Evidence |
O
|
GYG2 |
GYG2: Glycogenin-2 |
GYG1 |
GYG1, GYG: Glycogenin-1 |
16.410 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
16.400 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GHR |
GHR: Growth hormone receptor precursor |
16.400 |
Evidence |
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
16.390 |
Evidence |
O
|
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
16.290 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
16.290 |
Evidence |
O
|
FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
16.290 |
Evidence |
|
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
16.290 |
Evidence |
|
VDR |
VDR, NR1I1: Vitamin D3 receptor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
16.290 |
Evidence |
|
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
16.290 |
Evidence |
|
SF3A2 |
SF3A2, SAP62: Splicing factor 3A subunit 2 |
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
16.190 |
Evidence |
O
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
16.110 |
Evidence |
O
|